Relay Therapeutics (RLAY) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free RLAY Stock Alerts $6.36 +0.46 (+7.80%) (As of 01:16 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Relay Therapeutics Short Interest DataCurrent Short Volume11,170,000 sharesPrevious Short Volume11,810,000 sharesChange Vs. Previous Month-5.42%Dollar Volume Sold Short$92.71 millionShort Interest Ratio / Days to Cover10.0Last Record DateMarch 31, 2024Outstanding Shares131,180,000 sharesPercentage of Shares Shorted8.52%Today's Trading Volume832,918 sharesAverage Trading Volume1,137,928 sharesToday's Volume Vs. Average73% Short Selling Relay Therapeutics ? Sign up to receive the latest short interest report for Relay Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLAY Short Interest Over TimeRLAY Days to Cover Over TimeRLAY Percentage of Float Shorted Over Time Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Relay Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202411,170,000 shares $92.71 million -5.4%N/A10 $8.30 3/15/202411,810,000 shares $93.89 million +7.4%N/A10.9 $7.95 2/29/202411,000,000 shares $110.22 million +12.1%N/A10.5 $10.02 2/15/20249,810,000 shares $104.67 million +3.8%N/A9.2 $10.67 1/31/20249,450,000 shares $87.41 million -16.3%11.0%9.5 $9.25 1/15/202411,290,000 shares $124.19 million -6.0%13.1%10.3 $11.00 Get the Latest News and Ratings for RLAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202312,010,000 shares $132.23 million -12.3%14.1%10.4 $11.01 12/15/202313,700,000 shares $138.92 million -6.4%16.1%11.5 $10.14 11/30/202314,630,000 shares $115.72 million -0.1%17.3%12.1 $7.91 11/15/202314,640,000 shares $125.17 million +1.5%17.3%12.7 $8.55 10/31/202314,430,000 shares $95.24 million +4.8%16.9%12.9 $6.60 10/15/202313,770,000 shares $106.58 million -29.0%16.3%13.5 $7.74 9/30/202319,400,000 shares $163.15 million -3.4%22.9%19.9 $8.41 9/15/202320,080,000 shares $188.15 million +1.0%23.7%21 $9.37 8/31/202319,890,000 shares $203.28 million -3.9%23.5%19.1 $10.22 8/15/202320,700,000 shares $219.83 million +5.5%24.5%18.3 $10.62 7/31/202319,630,000 shares $247.34 million -1.1%23.3%16.4 $12.60 7/15/202319,840,000 shares $242.64 million -3.1%23.8%14.7 $12.23 6/30/202320,480,000 shares $257.23 million -2.9%24.6%12.1 $12.56 6/15/202321,080,000 shares $269.61 million -0.4%25.3%12.3 $12.79 5/31/202321,160,000 shares $235.72 million -1.5%25.4%13.1 $11.14 5/15/202321,480,000 shares $221.03 million +8.5%25.8%13.6 $10.29 4/30/202319,800,000 shares $225.13 million +1.4%23.4%13 $11.37 4/15/202319,530,000 shares $340.60 million +3.3%23.1%13.3 $17.44 3/31/202318,910,000 shares $311.45 million +5.5%22.4%15.4 $16.47 3/15/202317,930,000 shares $295.85 million +0.8%21.3%13.8 $16.50 2/28/202317,780,000 shares $287.15 million +3.0%21.1%13 $16.15 2/15/202317,270,000 shares $317.25 million -0.6%20.6%12.9 $18.37 1/31/202317,380,000 shares $372.97 million -6.9%20.7%13 $21.46 1/15/202318,660,000 shares $387.57 million +10.5%22.2%14.7 $20.77 12/30/202216,890,000 shares $252.34 million +25.8%20.0%13.8 $14.94 12/15/202213,430,000 shares $230.59 million +7.5%15.9%12.2 $17.17 11/30/202212,490,000 shares $232.06 million -4.3%14.8%11.1 $18.58 11/15/202213,050,000 shares $258.39 million -3.1%15.4%10.5 $19.80 10/31/202213,460,000 shares $299.08 million +3.1%16.5%10.9 $22.22 10/15/202213,060,000 shares $254.80 million +7.2%16.1%10.4 $19.51 9/30/202212,180,000 shares $272.47 million +4.0%15.0%10.2 $22.37 9/15/202211,710,000 shares $293.69 million -25.0%15.9%9.2 $25.08 8/31/202215,620,000 shares $358.79 million -15.2%21.2%13.4 $22.97 8/15/202218,420,000 shares $386.27 million -1.8%25.1%18.1 $20.97Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report RLAY Short Interest - Frequently Asked Questions What is Relay Therapeutics' current short interest? Short interest is the volume of Relay Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 11,170,000 shares of RLAY short. Learn More on Relay Therapeutics' current short interest. What is a good short interest ratio for Relay Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLAY shares currently have a short interest ratio of 10.0. Learn More on Relay Therapeutics's short interest ratio. Is Relay Therapeutics' short interest increasing or decreasing? Relay Therapeutics saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 11,170,000 shares, a drop of 5.4% from the previous total of 11,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relay Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Relay Therapeutics: REGENXBIO Inc. (8.05%), CARGO Therapeutics, Inc. (13.63%), Cullinan Oncology, Inc. (5.49%), Mesoblast Limited (2.05%), Immatics (10.52%), BioCryst Pharmaceuticals, Inc. (15.64%), Cabaletta Bio, Inc. (17.62%), HilleVax, Inc. (2.90%), Novavax, Inc. (31.38%), ProKidney Corp. (31.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Relay Therapeutics stock? Short selling RLAY is an investing strategy that aims to generate trading profit from Relay Therapeutics as its price is falling. RLAY shares are trading up $0.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relay Therapeutics? A short squeeze for Relay Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLAY, which in turn drives the price of the stock up even further. How often is Relay Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLAY, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: RGNX Short Squeeze CRGX Short Squeeze CGEM Short Squeeze MESO Short Squeeze IMTX Short Squeeze BCRX Short Squeeze CABA Short Squeeze HLVX Short Squeeze NVAX Short Squeeze PROK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLAY) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders